Physician profile
Marlene Willen
NPI 1215955661
$1,143.13
in general payments reported to CMS, 2019-2025
18 companies · $97.80 in 2025
The $97.80 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $15.92 · 2021: $187 · 2022: $192 · 2023: $296 · 2024: $203 · 2025: $97.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $386.26 | 2023-2025 | Sotyktu |
| Amgen INC. | $133.15 | 2021-2024 | Otezla |
| Dermavant Sciences, INC. | $117.65 | 2022-2023 | Vtama |
| Pfizer INC. | $87.87 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $66.87 | 2019-2022 | |
| Almirall LLC | $62.38 | 2019-2022 | |
| Galderma Laboratories, L.P. | $50.00 | 2025 | |
| Celgene Corporation | $49.38 | 2019 | |
| Genzyme Corporation | $33.69 | 2021 | |
| Sun Pharmaceutical Industries INC. | $28.89 | 2022 | |
| Pierre Fabre Pharmaceuticals, INC. | $18.87 | 2025 | Hemangeol |
| Mayne Pharma Commercial LLC | $18.71 | 2023 | |
| Leo Pharma INC. | $16.90 | 2019 | |
| Convatec INC. | $16.44 | 2023 | |
| Organon LLC | $15.17 | 2025 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.96 | 2021 | |
| Incyte Corporation | $14.77 | 2021 | |
| Medimetriks Pharmaceuticals, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Willen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.